Resources

Your selections:

Clear all

Show Filters

We found 252 resources that match your search.

The following side effects have been associated with the use of raltegravir:

Document Date:

Document Date:

Document Date:

Required documentation of risk/benefit category and approval of clinical studies for inclusion of children by institutional review boards/ethics committees based on 45 CFR 46, Subpart D.

Document Date:

Document Date:

Ribasphere is a nucleoside analogue indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with peginterferon alfa-2a in patients 5 years of age and older with compensated liver disease not previously treated with interferon alpha, and in adult CHC patients…

Document Date:

Ribavirin is a nucleoside analogue indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with peginterferon alfa-2a in patients 5 years of age and older with compensated liver disease not previously treated with interferon alpha, and in adult CHC patients…

Document Date:

Document Date:

Document Date:

Document Date:

Rifampin is indicated in the treatment of all forms of tuberculosis.

Document Date:

Document Date:

The following side effects have been associated with the use of rifapentine:

Document Date:

The following serious and life-threatening side effects have been associated with the use of rilpivirine:

Document Date:

NORVIR is an HIV protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

Document Date:

Document Date:

Document Date:

Document Date:

Document Date:

Document Date:

.zip file contains: Case review on adverse events Safety training presentations on adverse events, expedited reporting and assessment, Expedited reporting via DAERS a safety training case study handout Training given in the Republic of South Africa in October 2016.

Document Date: